Abstract
This work details the outbreak and factors affecting the spread of novel coronavirus (COVID-19) in the Indian state of Maharashtra, which is considered as one of the most massive and deadly pandemic outbreaks. Observational data collected between 14 March 2020 and 4 May 2020 is statistically analyzed to determine the nonlinear behavior of the epidemic. It is followed by validating predicted results with real-time data. Proposed model is further used to obtain statistical summaries in which Grubbs tests for outlier detection have justified high values of evaluation metrics. Outliers are found to be pilot elements in an outbreak under considered region. Statistically, a significant correlation has been observed between dependent and explanatory variables. Transmission pattern of this virus is very much different from the SARS-CoV-1 virus. Key findings of this work will be predominant in maintaining environment conditions at healthcare facilities to reduce transmission rates at these most vulnerable places.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Study is aimed to make aware the government sources and public about the tentative outbreak by mid July in Indian state of Maharshtra to help them in prevention of spread. Study is not registered as it involves forecasting and data is not about diagnostic treatment of patient
Funding Statement
This research work has not received any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data used of infected patients is available freely for public. It does not require approval.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data has been taken from the Indian government website for COVID-19 as well as COVID-19 Maharashtra government portal.